Business Context and Reporting Period
This Form 8-K is a current report filed by MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) on September 3, 2021, regarding an event that occurred on September 1, 2021. The company is incorporated in New Jersey and operates in the pharmaceutical sector.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and does not contain financial statements or performance data.
Material Changes
The material change reported is the departure of a director due to death. On September 1, 2021, Robert C. Schroeder, a member of the board of directors, passed away. The company noted his valuable contributions and expressed sympathy to his family.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, risks, contingencies, or unusual items beyond the announcement of the director's passing.
Key Facts for Investors to Verify
- Confirmation of the vacancy on the Board of Directors following the death of Robert C. Schroeder.
- Any subsequent announcements regarding the appointment of a replacement director.
- Impact of this personnel change on board committee assignments or quorum requirements.